4//SEC Filing
Lubman Ellen 4
Accession 0000899243-21-018108
CIK 0001785530other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:30 PM ET
Size
10.3 KB
Accession
0000899243-21-018108
Insider Transaction Report
Form 4
Lubman Ellen
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2020-08-03+145,531→ 145,531 totalExercise: $1.56Exp: 2030-08-02→ Common Stock (145,531 underlying) - Award
Stock Option (right to buy)
2021-04-30+48,455→ 48,455 totalExercise: $16.00Exp: 2031-04-29→ Common Stock (48,455 underlying) - Award
Stock Option (right to buy)
2020-12-08+118,781→ 118,781 totalExercise: $4.77Exp: 2030-12-07→ Common Stock (118,781 underlying)
Footnotes (3)
- [F1]The option was granted on August 3, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024.
- [F2]The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024.
- [F3]The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001857842
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:30 PM ET
- Size
- 10.3 KB